Navigation Links
NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
Date:8/5/2009

d adverse side effects or inadequate therapeutic efficacy or tolerability; physician or patient reluctance to use Qutenza or NGX-1998, if approved; and other difficulties or delays in, clinical development of, and obtaining regulatory approval for NeurogesX' product candidates. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission. 

    NeurogesX, Inc.                     The Ruth Group
    Stephen Ghiglieri                   Sara Pellegrino (investors)
    Chief Financial Officer             (646) 536-7002
    (650) 358-3310                      spellegrino@theruthgroup.com

                                        Jason Rando (media)
                                        (646) 536-7025
                                        jrando@theruthgroup.com


'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
2. NeurogesX Added to Russell 3000 Index
3. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
4. NeurogesX to Present at Needham Life Sciences Conference
5. NeurogesX Receives European Commission Approval for Qutenza(TM)
6. NeurogesX Reports First Quarter 2009 Results
7. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
8. NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
9. NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update
10. NeurogesX Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
11. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , STOCKHOLM, November 20 /PRNewswire/ -...he European Investment Fund (EIF) has entered into...o-investment fund will be,managed by Karolinska De...folio of early-stage pharmaceutical and medical te...M Euros in the co-investment fund. The agreement,r...
(Date:11/20/2009)... METTLER TOLEDO recently announ... Process Optimization Using At-Line Particle Chara...2, 2009. In this webinar, the application of in s...ap the design space and optimize a series of rolle...w rates, and roller compaction forces. , ...
(Date:11/19/2009)...st people would like to be able to charge their ce...nd not too often. A recent discovery made by UC Sa...sed supercapacitors that could do just this. , ...Letters , Prabhakar Bandaru, a professor in the UC...ing, along with graduate student Mark Hoefer, have...
(Date:11/19/2009)..., SEATTLE, Nov. 19 Om...unaudited financial results for the third quarter ...ed September 30, 2009, Omeros reported a net loss ...o a net loss of $7.4 million, or $2.54 per share, ...nded September 30, 2009, the Company reported a ne...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...Eden Prairie-,based molecular diagnostics service ...s appointed Paul J. Hoedeman as its CFO, and Eliza...ory. Mr. Hoedeman was recently CFO of Edwin Watts...at Home Depot, CFO and CIO of Allied Signal,Aerosp...He holds a J.D.,from William Mitchell College of L...
...ica, Oct. 11, Iomai Corporation (Nasdaq: IOMI ) t... Gregory Glenn, M.D., presented an,overview of the...,travelers, diarrhea and the implications such a v... Symposia: Challenges of Global Vaccine,Developmen...th, Dr. Glenn presented data from a Phase 2 field ...
...acy staff with the ability to manage ...EW, Calif. and CHAMBERSBURG, Pa., Oct. 11, Omnicel...stem solutions to acute healthcare facilities, and...lth, today announced that Chambersburg,Hospital ha...inutes after,the successful installation of the Om...
Other Biology Technology:Access Genetics Announces New Executive Appointments 2Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference 2Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference 3Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference 4Chambersburg Hospital Streamlines Pharmacy Process and Increases Patient Safety With Omnicell WorkflowRx 5.0 2Chambersburg Hospital Streamlines Pharmacy Process and Increases Patient Safety With Omnicell WorkflowRx 5.0 3
(Date:11/20/2009)... contribute their abstracts to the World Congress ...st global meeting devoted to all aspects of osteop...e. The Congress will be held in Florence, Italy fr...an be submitted online at http://www.iofwco-ecceo..., 2010. , IOF and ESCEO are pleased to announce ...
(Date:11/20/2009)... single bacterial gene into yeast, researchers fro...s achieved three improvements in bioethanol produc...ol, less acetate and elimination of the major by-p...shed in the scientific journal Applied and Enviro...ol is made by the yeast Saccharomyces cerevisiae f...
(Date:11/20/2009)... Research Center (ERC) has been awarded a grant fr...methods of recovering and reusing the heat that wo...pression process in a carbon capture system. The g...n capture and sequestration, or storage (CCS), and... emitted into the atmosphere by coal-fired power p...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Delft breakthrough in bioethanol production from agricultural waste 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Nycomed Announces FDA Filing for Daxas 28R 29 in COPD 52082 1Nycomed Announces FDA Filing for Daxas 28R 29 in COPD 52082 2Nycomed Announces FDA Filing for Daxas 28R 29 in COPD 52082 3United Spinal Associations 2009 Independence Expo Aug 7th 8th in Orlando 3A Improving Life for the Disabled and the Aging 52079 1United Spinal Associations 2009 Independence Expo Aug 7th 8th in Orlando 3A Improving Life for the Disabled and the Aging 52079 2United Spinal Associations 2009 Independence Expo Aug 7th 8th in Orlando 3A Improving Life for the Disabled and the Aging 52079 3Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 1Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 2
... a cell, a virus often becomes dormant, turning of... trigger from its environment. When that trigger i... proteins through built-in positive-feedback loops...dback, production of something stimulates more pro...r faster, growth.) If the viral environment were p...
...te that, on average, they make about 15 food- and ... is, they make more than 15 times that -- more tha...ell study, Brian Wansink, the John S. Dyson Profes...ll, observed, "So many food decisions are made on ...ny more food decisions than we are aware of, he sa...
...f research, scientists at The University of Texas ...in, in exquisite molecular detail, how the estroge... , In the Sept. 24 issue of the journal, Nature C...s and proteins thought to play a part in breast ca...ified potential molecular drug targets. , "It,s ...
Other Biology News:A simple feedback resistor switch keeps latent HIV from awakening 2A simple feedback resistor switch keeps latent HIV from awakening 3'Mindless autopilot' drives people to underestimate food decisions 2New path from estrogen to survival in breast cancer cells described 2New path from estrogen to survival in breast cancer cells described 3
...es in your laboratory or fellow researchers want y...tractions, problems and delays. • Receive... us your idea and let us build it up and market it...ssurance in design, development, production, insta...
Topoisomerase I from Invitrogen
Eco RII (Bst NI) from Roche Applied Science
... Kit TNF-α Converting Enzyme Activity Kit ...CLES. The InnoZyme™ TACE Activity Kit is a s...man TACE activity in cell lysates and biological s...i-Human TACE-Coated 96-Well Plate is pre-coated wi...
Biology Products: